Logo Image
News|Slideshows|July 7, 2025

Highlighted Interviews from SNMMI 2025

Catch up on recent interviews with Jean-Luc C. Urbain, M.D., Amir Iravani, M.D., Liza Lindenberg, M.D., and more faculty from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 conference.

Whether it was preliminary research examining the potential of 18F-fluciclovine PET/CT for detection of multiple myeloma, new PET insights on neuroinflammation or an interview with new SNMMI president Jean-Luc U. Urbain, MD, we learned quite a bit during on-site interviews at the Society of Nuclear Imaging and Molecular Imaging (SNMMI) 2025 conference in New Orleans. Review the slideshow below to check out some of our on-site interviews from the conference.

Related to this article

View more
What CCTA-Based AI Detection of Coronary Inflammation May Reveal About Patients with No Traditional CV Risk Factors
What CCTA-Based AI Detection of Coronary Inflammation May Reveal About Patients with No Traditional CV Risk Factors
Elevated coronary inflammation, measured with the CCTA-derived and AI-enabled perivascular fat attenuation index (FAI) score, was associated with over a 12-fold higher risk for cardiovascular mortality in patients with no diabetes, hypertension, smoking history or obesity, according to new research presented at the European Society of Cardiology (ESC) Congress.
Read more
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Read more